Mark Womack

776 citations
14 papers · 63 · h-index 4

Impact in

    • Pancreatic and Hepatic Oncology Research
    • Cancer Cells and Metastasis
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 6
    • Cancer Immunotherapy and Biomarkers 3
    • PARP inhibition in cancer therapy 3
    • Cancer Cells and Metastasis 2
    • Colorectal Cancer Treatments and Studies 2
    • Heat shock proteins research 3

Mark Womack

13 papers receiving 63 citations

Peers

Mark Womack
Comparison fields: 5 of 19
  • Oncology 32
  • Cancer Research 17
  • Cell Biology 9
  • Biotechnology 4
  • Pulmonary and Respiratory Medicine 12
Replace Chrysa Koukorava with:
Chrysa Koukorava United Kingdom
Pierre Painsec France
Roderic Espín Spain
Howard Stotler United States
Gwo‐Shu M. Lee United States
Meilin Xue China
Huiying Sun China
Alexis Jiaying Khng Singapore
Neus Calbet‐Llopart Spain
Sara Martínez United States
Mark Womack relative to Chrysa Koukorava United Kingdom Chrysa Koukorava's profile →
Citations per field
00.5×1.7×
Chrysa Koukorava · 1×
Citations per year

Countries citing papers authored by Mark Womack

Since Specialization
Citations

This map shows the geographic impact of Mark Womack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Womack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Womack more than expected).

Fields of papers citing papers by Mark Womack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Womack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Womack. The network helps show where Mark Womack may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Womack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Womack Line = papers co-authored together Mark Womack links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201739
2 20164
3 20203
4 20243
5 20192
6 20242
7 20242
8 19972
9 20162
10
Playing it Smart
20081
11 20181
12 20211
13 20141
14 20240

About Mark Womack

Mark Womack is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Neurology, having authored 14 papers that have together received 63 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Heat shock proteins research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), PARP inhibition in cancer therapy (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Cells and Metastasis (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (32 citations), Cancer Research (17 citations), Cell Biology (9 citations), Biotechnology (4 citations) and Pulmonary and Respiratory Medicine (12 citations). Mark Womack has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Johanna C. Bendell, Laura M. DeBusk, Cassie M. Lane, Margaret A. Tempero, Patrick Murphy, James D. Peyton, Henry Q. Xiong, David Waterhouse, Dianna Shipley and Andrew H. Ko. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Cancers and Studies in English Literature 1500-1900.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact